As the September 1, 2023 deadline for Centers for Medicare & Medicaid Services (CMS) to publish the first 10 “selected drugs” subject to...
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Reed Smith LLP
Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry